Literature DB >> 22771576

A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Arash Mohebati1, Allison Knutson, Xi Kathy Zhou, Judith J Smith, Powel H Brown, Andrew J Dannenberg, Eva Szabo.   

Abstract

Screening and recruitment of qualified subjects for clinical trials is an essential component of translational research, and it can be quite challenging if the most efficient recruitment method is not utilized. In this report, we describe a successful web-based screening and accrual method used in a randomized prospective chemoprevention clinical trial with urinary biomarker endpoints. The targeted study population was a group of at-risk healthy current smokers with no evidence of lung disease. Craigslist was used as the sole recruitment modality for this study. All interested subjects were directed to a pre-screening website, in which subject questionnaire responses were linked to the study coordinator's secure e-mail account. Of the 429 initial inquiries, 189 individuals were initially eligible based on the questionnaire response. One hundred twenty-two people were telephone-screened, of whom 98 subjects were consented, 84 were randomized and 77 subjects completed the study successfully. Utilizing this single web-based advertising strategy, accrual for the trial was completed 7 months prior to the projected date. Craigslist is a cost effective and efficient web-based resource that can be utilized in accruing subjects to some chemoprevention trials. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771576      PMCID: PMC3460548          DOI: 10.1016/j.cct.2012.07.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  17 in total

1.  Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research Group.

Authors:  N Cosgrove; N O Borhani; G Bailey; P Borhani; J Levin; M Hoffmeier; S Krieger; L C Lovato; H Petrovitch; T Vogt; A C Wilson; V Breeson; J L Probstfield
Journal:  Control Clin Trials       Date:  1999-04

2.  Recruitment for controlled clinical trials: literature summary and annotated bibliography.

Authors:  L C Lovato; K Hill; S Hertert; D B Hunninghake; J L Probstfield
Journal:  Control Clin Trials       Date:  1997-08

3.  Accrual to clinical trials.

Authors:  R E Wittes; M A Friedman
Journal:  J Natl Cancer Inst       Date:  1988-08-17       Impact factor: 13.506

4.  ResearchMatch: a national registry to recruit volunteers for clinical research.

Authors:  Paul A Harris; Kirstin W Scott; Laurie Lebo; Niknik Hassan; Chad Lightner; Jill Pulley
Journal:  Acad Med       Date:  2012-01       Impact factor: 6.893

5.  Monitoring recruitment effectiveness and cost in a clinical trial.

Authors:  W M Bjornson-Benson; T B Stibolt; K A Manske; K J Zavela; D J Youtsey; A S Buist
Journal:  Control Clin Trials       Date:  1993-04

Review 6.  Recruitment experience in clinical trials: literature summary and annotated bibliography.

Authors:  D B Hunninghake; C A Darby; J L Probstfield
Journal:  Control Clin Trials       Date:  1987-12

7.  Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial.

Authors:  G E Goodman; B Valanis; F L Meyskens; J H Williams; B J Metch; M D Thornquist; G S Omenn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-05       Impact factor: 4.254

8.  Effect of recruitment strategy on types of subjects entered into a primary prevention clinical trial.

Authors:  A C King; R B Harris; W L Haskell
Journal:  Ann Epidemiol       Date:  1994-07       Impact factor: 3.797

9.  Recruitment for an efficacy study in chemoprevention--the Concerned Smoker Study.

Authors:  A Arnold; B Johnstone; B Stoskopf; P Skingley; G Browman; M Levine; W Hryniuk
Journal:  Prev Med       Date:  1989-09       Impact factor: 4.018

10.  Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer.

Authors:  T Camerini; G De Palo; L Mariani; E Marubini; A Costa; U Veronesi
Journal:  Tumori       Date:  1999 Jul-Aug
View more
  8 in total

1.  Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer.

Authors:  Nagi B Kumar; Gwendolyn P Quinn; Mark G Alexandrow; Jhanelle Gray; Michael Schell; Steve Sutton; Eric B Haura
Journal:  J Clin Trials       Date:  2014-09

2.  Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.

Authors:  Arash Mohebati; Ginger L Milne; Xi Kathy Zhou; Anna J Duffield-Lillico; Jay O Boyle; Allison Knutson; Brian P Bosworth; Philip J Kingsley; Lawrence J Marnett; Powel H Brown; Esther G Akpa; Eva Szabo; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2013-05-16

3.  Using an e-Cigarette is Like Eating Tofu When You Really Want Meat.

Authors:  Rachel L Goldberg; Janine K Cataldo
Journal:  Am J Health Behav       Date:  2018-09-01

4.  Craigslist versus print newspaper advertising for recruiting research participants for alcohol studies: Cost and participant characteristics.

Authors:  Christopher J Gioia; Linda Carter Sobell; Mark B Sobell; Sangeeta Agrawal
Journal:  Addict Behav       Date:  2015-11-19       Impact factor: 3.913

5.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

6.  Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis.

Authors:  Caroline Hamm; Dora Cavallo-Medved; Devinder Moudgil; Lee McGrath; John Huang; Yueyang Li; Tyler W Stratton; Tyler Robinson; Krista Naccarato; Stephen Sundquist; Janet Dancey
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

7.  Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.

Authors:  Delvin Kwamboka Nyasani; Gaudensia Nzembi Mutua; Rose Miroyo Sajabi; Jane Wairimu Ng'ang'a; John Ndungu Gachie; Amos Macharia Maina; Laura Lunani Lusike; Aggrey Omu Anzala; Matthew A Price; Gloria Omosa Manyonyi
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

8.  Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).

Authors:  S Walter; T B Clanton; O G Langford; M S Rafii; E J Shaffer; J D Grill; G A Jimenez-Maggiora; R A Sperling; J L Cummings; P S Aisen
Journal:  J Prev Alzheimers Dis       Date:  2020
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.